Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Combined Single and Multiple Rising Dose Study of the Safety and Pharmacokinetics of Metyrapone/Oxazepam Combination (EMB-001)

NCT02406066 is registered in ClinicalTrials.gov with Embera NeuroTherapeutics, Inc. as lead sponsor.

NCT NCT02406066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Combined Single and Multiple Rising Dose Study of the Safety and Pharmacokinetics of Metyrapone/Oxazepam Combination (EMB-001)
Lead sponsor
Embera NeuroTherapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2016
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorder, tobacco use disorder